EDOXABAN ANTICOAGULATION FOR GYNECOLOGICAL CANCER WITH VENOUS THROMBOEMBOLISM

被引：0
|
作者：
Odajima, S. [1 ]
Seki, T. [1 ]
Saito, R. [1 ]
Kato, S. [1 ]
Suzuki, E. [1 ]
Saito, M. [1 ]
Yanagida, S. [1 ]
Yanaihara, N. [1 ]
Takano, H. [1 ]
Yamada, K. [1 ]
Okamoto, A. [1 ]
机构：
[1] Jikei Univ, Sch Med Obstet & Gynecol, Tokyo, Japan
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2020年 / 30卷
关键词：
D O I：
10.1136/ijgc-2020-IGCS.223
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCS20_127
引用
收藏
页码：A106 / A106
页数：1
相关论文
共 50 条
  • [41] Anticoagulation for the long-termtreatment of venous thromboembolism in people with cancer
    Kahale, Lara A.
    Hakoum, Maram B.
    Tsolakian, Ibrahim G.
    Matar, Charbel F.
    Terrenato, Irene
    Sperati, Francesca
    Barba, Maddalena
    Yosuico, Victor E. D.
    Schunemann, Holger
    Akl, Elie A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (06):
  • [42] Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer
    Akl, E. A.
    Barba, M.
    Rohilla, S.
    Terrenato, I
    Sperati, F.
    Muti, P.
    Schuenemann, H. J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (02):
  • [43] Anticoagulation for prevention and treatment of cancer-related venous thromboembolism
    Barsam, Sarah J.
    Patel, Raj
    Arya, Roopen
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (06) : 764 - 777
  • [44] Comparing Anticoagulation Strategies for Venous Thromboembolism Associated With Active Cancer
    Fujisaki, Tomohiro
    Sueta, Daisuke
    Yamamoto, Eiichiro
    Buckley, Conor
    Correia, Guilherme Sacchi de Camargo
    Aronson, Julia
    de Lara, Paulino Talloen
    Fujisue, Koichiro
    Usuku, Hiroki
    Matsushita, Kenichi
    Mehran, Roxana
    Dangas, George D.
    Tsujita, Kenichi
    JACC: CARDIOONCOLOGY, 2024, 6 (01): : 99 - 113
  • [45] Oral Anticoagulation for Primary Prophylaxis of Venous Thromboembolism in Patients with Cancer
    Aronow, Wilbert S.
    Shamliyan, Tatyana A.
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (08): : 902 - 907
  • [46] Recurrent venous thromboembolism during anticoagulation with edoxaban or warfarin: A post hoc analysis of the Hokusai-VTE trial
    Eichinger, Sabine
    Lin, Min
    Shi, Minggao
    Grosso, Michael A.
    Kyrle, Paul A.
    THROMBOSIS RESEARCH, 2020, 195 : 209 - 214
  • [47] Risk impact of edoxaban in the management of stroke and venous thromboembolism
    Hurst, Katherine V.
    O'Callaghan, John Matthew
    Handa, Ashok
    VASCULAR HEALTH AND RISK MANAGEMENT, 2016, 12 : 329 - 335
  • [48] Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
    Bueller, Harry R.
    Decousus, Herve
    Grosso, Michael A.
    Mercuri, Michele
    Middeldorp, Saskia
    Prins, Martin H.
    Raskob, Gary E.
    Schellong, Sebastian M.
    Schwocho, Lee
    Segers, Annelise
    Shi, Minggao
    Verhamme, Peter
    Wells, Phil
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (15): : 1406 - 1415
  • [49] Edoxaban Versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
    史振宇
    临床误诊误治, 2014, 27 (03) : 102 - 102
  • [50] Venous Thromboembolism in Women with Cancer with an Additional Focus on Breast and Gynecological Cancers
    Matzdorff, Axel
    HAMOSTASEOLOGIE, 2022, 42 (05): : 309 - 319
12345